SCHEMBL5569380

SCHEMBL5569380

NC(C(=O)Nc1ccc(C2(CN3CCCC3)CC2)cc1)c1ccccc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RY1 P47900 1/20 0.43
▸ KCNQ2 O43526 1/20 0.39
▸ FPR2 P25090 4/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ THRB P10828 1/20 0.38
▸ HTR3A P46098 1/20 0.37
▸ NPC1 O15118 3/20 0.37
▸ TP53 P04637 3/20 0.37
▸ RAB9A P51151 3/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ MAPT P10636 1/20 0.37
▸ MCL1 Q07820 1/20 0.37
▸ PKM P14618 1/20 0.36
▸ F10 P00742 4/20 0.36
▸ F2 P00734 1/20 0.36
▸ OPRK1 P41145 1/20 0.36
▸ LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5570412 0.84 P2RY1 (0.46) P2RY1KCNQ2MEN1KMT2AALDH1A1
SCHEMBL5566711 0.81 MAPT (0.44) P2RY1KCNQ2FPR2MEN1KMT2A
SCHEMBL5567510 0.76 AAK1 (0.50) P2RY1ALDH1A1MAPT
SCHEMBL5569965 0.76 F10 (0.45) P2RY1FPR2MEN1KMT2AALDH1A1
SCHEMBL5566695 0.75 KMT2A (0.43) KCNQ2MEN1KMT2AALDH1A1KDM4E
SCHEMBL5570588 0.75 ULK1 (0.40) P2RY1KCNQ2MEN1KMT2AALDH1A1
SCHEMBL5569392 0.74 CHEK1 (0.49) P2RY1
SCHEMBL5569500 0.71 OPRK1 (0.45) OPRK1
SCHEMBL5565619 0.69 CNR1 (0.51) P2RY1ALDH1A1MAPT
SCHEMBL4518392 0.69 HDAC4 (0.56) MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250415-B2 1,1-Disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, β-aminoacids, α-aminoacids and derivatives thereof as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-07-31 — — US disclosed
Send feedback